These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11193886)

  • 1. Molecular and biological determinants of the cytotoxic actions of camptothecins. Perspective for the development of new topoisomerase I inhibitors.
    Kohn KW; Pommier Y
    Ann N Y Acad Sci; 2000; 922():11-26. PubMed ID: 11193886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The other camptothecins: recent advances with camptothecin analogues other than irinotecan and topotecan].
    Lavergne O; Bigg DC
    Bull Cancer; 1998 Dec; Spec No():51-8. PubMed ID: 9932086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Camptothecin design and delivery approaches for elevating anti-topoisomerase I activities in vivo.
    Burke TG; Bom D
    Ann N Y Acad Sci; 2000; 922():36-45. PubMed ID: 11193923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in topoisomerase I-targeting agents, camptothecin analogues.
    Kim DK; Lee N
    Mini Rev Med Chem; 2002 Dec; 2(6):611-9. PubMed ID: 12370044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocamptothecin, an E-ring-modified camptothecin analogue, generates new topoisomerase I-mediated DNA breaks.
    Bailly C; Lansiaux A; Dassonneville L; Demarquay D; Coulomb H; Huchet M; Lavergne O; Bigg DC
    Biochemistry; 1999 Nov; 38(47):15556-63. PubMed ID: 10569939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based analysis of the effects of camptothecin on the activities of human topoisomerase I.
    Champoux JJ
    Ann N Y Acad Sci; 2000; 922():56-64. PubMed ID: 11193925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Camptothecins in clinical development.
    Zunino F; Pratesi G
    Expert Opin Investig Drugs; 2004 Mar; 13(3):269-84. PubMed ID: 15013945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A symphony for the camptothecins].
    Lansiaux A; Bailly C
    Bull Cancer; 2003 Mar; 90(3):239-45. PubMed ID: 12801826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review camptothecin: current perspectives.
    Li QY; Zu YG; Shi RZ; Yao LP
    Curr Med Chem; 2006; 13(17):2021-39. PubMed ID: 16842195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of resistance to camptothecins.
    Saleem A; Edwards TK; Rasheed Z; Rubin EH
    Ann N Y Acad Sci; 2000; 922():46-55. PubMed ID: 11193924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship of alkyl camptothecin esters.
    Cao Z; Pantazis P; Mendoza J; Early J; Kozielski A; Harris N; Vardeman D; Liehr J; Stehlin JS; Giovanella B
    Ann N Y Acad Sci; 2000; 922():122-35. PubMed ID: 11193888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of camptothecin topoisomerase I inhibitors.
    Herben VM; Ten Bokkel Huinink WW; Schellens JH; Beijnen JH
    Pharm World Sci; 1998 Aug; 20(4):161-72. PubMed ID: 9762728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of camptothecin esters.
    Liehr JG; Harris NJ; Mendoza J; Ahmed AE; Giovanella BC
    Ann N Y Acad Sci; 2000; 922():216-23. PubMed ID: 11193897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergism between cisplatin and topoisomerase I inhibitors, NB-506 and SN-38, in human small cell lung cancer cells.
    Fukuda M; Nishio K; Kanzawa F; Ogasawara H; Ishida T; Arioka H; Bojanowski K; Oka M; Saijo N
    Cancer Res; 1996 Feb; 56(4):789-93. PubMed ID: 8631015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CPT-11: a novel antitumor drug.
    Armand JP
    Jpn J Cancer Res; 1994 Aug; 85(8):inside front cover. PubMed ID: 7928619
    [No Abstract]   [Full Text] [Related]  

  • 16. Schedule-dependent efficacy of camptothecins in models of human cancer.
    Houghton PJ; Stewart CF; Zamboni WC; Thompson J; Luo X; Danks MK; Houghton JA
    Ann N Y Acad Sci; 1996 Dec; 803():188-201. PubMed ID: 8993512
    [No Abstract]   [Full Text] [Related]  

  • 17. The camptothecins.
    Pizzolato JF; Saltz LB
    Lancet; 2003 Jun; 361(9376):2235-42. PubMed ID: 12842380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Camptothecin and its analogues: a review on their chemotherapeutic potential.
    Sriram D; Yogeeswari P; Thirumurugan R; Bal TR
    Nat Prod Res; 2005 Jun; 19(4):393-412. PubMed ID: 15938148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Homocamptothecins--novel promising anticancer drugs as inhibitors of topoisomerase I].
    Yang S; Zhang WN
    Yao Xue Xue Bao; 2004 May; 39(5):396-400. PubMed ID: 15338888
    [No Abstract]   [Full Text] [Related]  

  • 20. Animal models for studying the action of topoisomerase I targeted drugs.
    Thompson J; Stewart CF; Houghton PJ
    Biochim Biophys Acta; 1998 Oct; 1400(1-3):301-19. PubMed ID: 9748639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.